DINA PUGLISSI: Open Payments
NPI 1013084763 · GARDEN CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$867 in 38 payments from 12 companies in 2025. Trend: 2023 $1,003 · 2024 $1,448 · 2025 $867
Food & beverage: $867
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $129 |
| ABBVIE INC. | 5 | $114 |
| PFIZER INC. | 6 | $114 |
| Regeneron Healthcare Solutions, Inc. | 3 | $105 |
| E.R. Squibb & Sons, L.L.C. | 4 | $90 |
| Janssen Biotech, Inc. | 3 | $63 |
| Amgen Inc. | 3 | $60 |
| Incyte Corporation | 2 | $54 |
| Lilly USA, LLC | 2 | $47 |
| LEO Pharma Inc. | 2 | $43 |
Products named: DUPIXENT, CIBINQO, Sotyktu, TREMFYA, OTEZLA, SKYRIZI, OPZELURA, BOTOX.
Industry payments across NY — which companies pay providers there.
